Loading
Life sciences · Journal article
Discover Public Health · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Sarcopenic obesity (SO) a phenotype associated with worse metabolic outcomes than either sarcopenia or obesity alone. Its association with cardiometabolic multimorbidity (CMM) remains poorly characterized in South Asian populations, despite India’s disproportionate burden of both conditions. This cross-sectional analysis used data from 46,563 participants aged ≥ 50 years from the Longitudinal Aging Study in India. Possible sarcopenia was defined using Asian Working Group for Sarcopenia 2025 age-stratified handgrip strength cutoffs; obesity was defined as BMI ≥ 25 kg/m². Participants were classified as Normal, Sarcopenia only, Obesity only, or Sarcopenic obesity. CMM was defined as two or more of five self-reported conditions: hypertension, diabetes, chronic heart disease, stroke, and hypercholesterolemia. Weighted multivariable logistic regression examined the association between sarcopenia-obesity status and CMM, adjusting for age, sex, residence, education, wealth, physical activity, alcohol use, tobacco use, and functional limitation. CMM prevalence was 12.9%. Relative to the Normal group, odds of CMM were significantly elevated among participants with sarcopenic obesity (OR 3.14, 95% CI 2.56–3.85), followed by obesity only (OR 1.92, 95% CI 1.60–2.30), and sarcopenia only (OR 1.18, 95% CI 1.02–1.35). Higher wealth, education, urban residence, and functional limitation were also associated with higher odds of CMM, while daily physical activity was associated with lower odds. SO was associated with substantially higher odds of CMM than either sarcopenia or obesity alone among Indian adults aged 50 years and older, supporting integrated screening approaches assessing both muscle function and adiposity in this population.